Perrigo Co. (PRGO) Announces U.S. FDA Approval of Generic Monistat -1 Combo Pack 8:41 AM ET - StreetInsider Perrigo Company today announced that it has received final approval from the U.S. Food and Drug Administration for its abbreviated new drug application for over-the-counter Miconazole Nitrate Vaginal Cream and Suppository, a generic to Monistat -1 Combination Pack. Monistat-1 has annual retail sales of approximately $90 million dollars
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.